SEATTLE--(BUSINESS WIRE)--Frazier Healthcare Partners, a leading provider of growth capital to healthcare companies, announced today the expansion of its investment team with the promotion of Philip Zaorski and the addition of Ryan Lucero to the Growth Buyout team.
“We are proud to recognize the achievements of Phil Zaorski with this well-deserved promotion,” said Ben Magnano, General Partner. “During his tenure with Frazier, Phil has proven himself to be an important member of our team and an invaluable resource for our portfolio companies. We are also thrilled that Mr. Lucero has chosen to join Frazier as he is a well-respected professional with extensive experience in middle-market private equity. We look forward to the contributions of Phil and Ryan as we continue to seek new investment opportunities and work with our existing portfolio companies to accelerate growth and increase value.”
Philip Zaorski, Vice President – Mr. Zaorski joined Frazier as an associate in 2012 and has broad experience in growth buyout investing in all sectors of healthcare including multi-site provider services, outsourced provider and payor services, medical products and distribution, and pharmaceutical services. Prior to Frazier, he worked for RBC Capital Markets in its healthcare investment banking group based in New York.
Ryan Lucero, Vice President – Mr. Lucero comes to Frazier after five years with Kohlberg and Company in New York where he focused on leveraged buyout and growth equity investments. At Kohlberg, he was responsible for the origination, evaluation, and management of investments across a variety of sectors, including healthcare, business services, and financial services. Previously, Mr. Lucero worked for J.P. Morgan in the Investment Banking Division in New York.
About Frazier Healthcare Partners
Founded in 1991, Frazier Healthcare Partners is a leading provider of growth and venture capital to healthcare companies. With nearly $3.0 billion total capital raised, Frazier has invested in over 170 companies, with investment types ranging from company creation and venture capital to buyouts of profitable lower-middle market companies. The firm’s Growth Buyout team invests in healthcare and pharmaceutical services, medical products and related sectors. The Life Sciences team invests in therapeutics and related areas that are addressing unmet medical needs through innovation. Frazier has offices in Seattle, WA and Menlo Park, CA, and invests broadly across the US, Canada, and Europe.
For more information about Frazier Healthcare Partners, visit the company's website at http://www.frazierhealthcare.com.